SLRN - ACELYRIN, Inc.
2.27
0.040 1.762%
Share volume: 4,076,542
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.23
0.04
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-19-2025 | 05-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 82.774 M | 93.025 M | 43.938 M | 85.127 M | 59.855 M | |
| Selling general and admin | 24.742 M | 16.643 M | 12.326 M | 13.098 M | 17.717 M | |
| Research and development | 58.032 M | 76.382 M | 31.612 M | 72.029 M | 42.138 M | |
| Total expenses | 82.774 M | 93.025 M | 54.747 M | 85.712 M | 59.855 M | |
| 12.38% | -41.15% | 56.56% | -30.17% | |||
| Operating income | -82.774 M | -93.025 M | -54.747 M | -85.712 M | -59.855 M | |
| Ebit | -44.123 M | -94.119 M | -56.083 M | -85.110 M | -59.922 M | |
| Pretax income | -34.973 M | -85.672 M | -48.548 M | -79.033 M | -55.264 M | |
| 144.97% | -43.33% | 62.79% | -30.07% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -34.973 M | -85.672 M | -48.548 M | -79.033 M | -55.264 M | |
| -144.97% | 43.33% | -62.79% | 30.07% |